Evidence map›Paper›PMID 29311308›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions.

Rohit A Panchakshari, Xuefei Zhang, Vipul Kumar, Zhou Du, Pei-Chi Wei, Jennifer Kao, Junchao Dong, Frederick W Alt

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The LIM-domain-only protein LMO2 and its binding partner LDB1 are differentially required for class switch recombination.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. DNA Damage Response and Repair in Adaptive Immunity.Frontiers in cell and developmental biology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rohit A PanchakshariHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Xuefei ZhangHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Vipul KumarHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Zhou DuHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Pei-Chi WeiHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Jennifer KaoHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Junchao DongHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Frederick W AltHoward Hughes Medical Institute, Harvard Medical School, Boston, MA 02115; alt@enders.tch.harvard.edu.

Funding

Mechanisms that Regulate Antibody Class Switch Recombination and Somatic HypermutationR37AI077595 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI Frederick W. Alt · 2019 to 2026
$4.6M
Molecular Mechanisms of Class Switch RecombinationR01AI077595 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI ALT, FREDERICK W. · 2009 to 2018
$4.3M
Alternative End-Joining in DNA Repair and Chromosomal TranslocationsF30CA189740 · NCI · HARVARD MEDICAL SCHOOL · PI KUMAR, VIPUL · 2014 to 2018
$197k
Howard Hughes Medical InstituteNCI NIH HHS F30 CA189740NIAID NIH HHS R01 AI077595NIAID NIH HHS R37 AI077595
6 · The paper itself

Abstract

Ig heavy chain (IgH) class switch recombination (CSR) in B lymphocytes switches IgH constant regions to change antibody functions. CSR is initiated by DNA double-strand breaks (DSBs) within a donor IgH switch (S) region and a downstream acceptor S region. CSR is completed by fusing donor and acceptor S region DSB ends by classical nonhomologous end-joining (C-NHEJ) and, in its absence, by alternative end-joining that is more biased to use longer junctional microhomologies (MHs). Deficiency for DSB response (DSBR) factors, including ataxia telangiectasia-mutated (ATM) and 53BP1, variably impair CSR end-joining, with 53BP1 deficiency having the greatest impact. However, studies of potential impact of DSBR factor deficiencies on MH-mediated CSR end-joining have been technically limited. We now use a robust DSB joining assay to elucidate impacts of deficiencies for DSBR factors on CSR and chromosomal translocation junctions in primary mouse B cells and CH12F3 B-lymphoma cells. Compared with wild-type, CSR and c-myc to S region translocation junctions in the absence of 53BP1, and, to a lesser extent, other DSBR factors, have increased MH utilization; indeed, 53BP1-deficient MH profiles resemble those associated with C-NHEJ deficiency. However, translocation junctions between

Indexed as

DNA Breaks, Double-StrandedDNA End-Joining RepairImmunoglobulin Class SwitchingTranslocation, GeneticAnimalsCell LineHigh-Throughput Nucleotide SequencingMiceclass switch recombinationDNA repairmicrohomology-mediated end-joiningnonhomologous end-joining

Identifiers

PMID29311308
PMCPMC5789958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.